Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1

Title
Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 379, Issue 7, Pages 645-654
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2018-08-16
DOI
10.1056/nejmoa1711460

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started